Portfolio company
Third Arc Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops multifunctional antibodies to treat solid tumours and inflammatory diseases for the healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Arch Oncology
This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
Pheon Therapeutics
The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
3T Biosciences
The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
TenSixty Bio
The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.